Brief: CNS Pharmaceuticals Reports Quarterly Loss Per Share Of $0.17
12/03/2020 22:00
March 12 (Reuters) - CNS Pharmaceuticals Inc CNSP.O :
* CNS PHARMACEUTICALS ANNOUNCES BUSINESS HIGHLIGHTS AND 2019
FOURTH QUARTER FINANCIAL RESULTS
* CNS PHARMACEUTICALS- QTRLY LOSS PER SHARE $0.17
Source text for Eikon: ID:nPn6smGs1a
Further company coverage: CNSP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CNS Pharmaceuticals
See all newsCNS Pharmaceuticals Q2 net loss widens, cash rises after financing
CNS Pharmaceuticals Inc expected to post a loss of 24 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:44 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM
Brief: Cns Pharmaceuticals Appoints Rami Levin As CEO Effective Jan 1, 2026